Company: BIAF
Filing Date: 2025-10-09
Form Type: 8-K
Source: 0001493152-25-017627
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-10-09
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item
1.01. Entry into a Material Definitive Agreement.

Registered
Direct Offering

On
October 8, 2025, bioAffinity Technologies, Inc. (the “ Company”) entered into a securities purchase agreement (the “ Purchase
Agreement”) with institutional investors (the “ Purchasers”), pursuant to which the Company agreed to issue to the Purchasers
in a registered direct offering (the “ Offering”), 720,000 shares (the “ Shares”) of the Company’s common
stock, par value $0.007 per share (the “ Common Stock”).

The
Offering closed on October 9, 2025 (the “ Closing Date”), and the Company received aggregate gross proceeds of approximately
$1.8 million before deducting placement agent fees and other offering expenses payable by the Company. The Shares are being offered by
the Company pursuant to a shelf registration statement on Form S-3 (File No. 333-275608), which was declared effective by the Securities
and Exchange Commission on November 27, 2023 (as amended from time to time, the “ Registration Statement”).

Pursuant
to the terms of the Purchase Agreement, until November 14, 2025, the Company has agreed not to issue (or enter into any agreement to
issue) any shares of Common Stock or Common Stock Equivalents (as defined in the Purchase Agreement), subject to certain exceptions.
The Company has further agreed not to enter into an agreement involving any Variable Rate Transaction (as defined in the Purchase Agreement)
until six (6) months following the Closing Date, provided however, that the prohibition on “at the market offerings” and
equity lines of credit shall expire on November 14, 2025. In addition, each of the Company’s officers and directors have entered
into lock-up agreements with the Company pursuant to which each of them has agreed not to, for a period of 60 days from the Closing Date,
offer, sell, transfer or otherwise dispose of the Company’s securities, subject to certain exceptions.

WallachBeth
Capital, LLC acted as the exclusive placement agent (the “ Placement Agent”) on a “reasonable best efforts” basis,
in connection with the Offering pursuant to that certain placement agency agreement, dated October 8, 2025 (the “ Placement Agency
Agreement”), by and between the Company and the Placement Agent. Pursuant to the Placement Agency Agreement, the Placement Agent
will receive a cash fee of 8